Identification of highly immunogenic epitopes in the SARS-CoV-2 Spike protein to produce monoclonal antibodies
L. Fernandez Barat (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), L. Bueno (Barcelona, Spain), R. Farriol (Barcelona, Spain), E. Porta (Barcelona, Spain), À. López-Gavin (Barcelona, Spain), A. Motos (Barcelona, Spain), R. Aguilar (Barcelona, Spain), M. Vidal (Barcelona, Spain), A. Jiménez (Barcelona, Spain), R. Cabrera (Barcelona, Spain), N. Vázquez (Barcelona, Spain), E. Barbeta (Barcelona, Spain), M. Ferrer (Barcelona, Spain), A. Palomeque (Barcelona, Spain), G. Moncunill (Barcelona, Spain), M. Lozano (Barcelona, Spain), A. Garcia-Basteiro (Barcelona, Spain), C. Dobaño (Barcelona, Spain), A. Torres (Barcelona, Spain)
Source: International Congress 2022 – New mechanistic insights into acute and chronic interstitial lung disorders
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Fernandez Barat (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), L. Bueno (Barcelona, Spain), R. Farriol (Barcelona, Spain), E. Porta (Barcelona, Spain), À. López-Gavin (Barcelona, Spain), A. Motos (Barcelona, Spain), R. Aguilar (Barcelona, Spain), M. Vidal (Barcelona, Spain), A. Jiménez (Barcelona, Spain), R. Cabrera (Barcelona, Spain), N. Vázquez (Barcelona, Spain), E. Barbeta (Barcelona, Spain), M. Ferrer (Barcelona, Spain), A. Palomeque (Barcelona, Spain), G. Moncunill (Barcelona, Spain), M. Lozano (Barcelona, Spain), A. Garcia-Basteiro (Barcelona, Spain), C. Dobaño (Barcelona, Spain), A. Torres (Barcelona, Spain). Identification of highly immunogenic epitopes in the SARS-CoV-2 Spike protein to produce monoclonal antibodies. 2798
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|